Journal
IDCASES
Volume 25, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.idcr.2021.e01197
Keywords
COVID-19; SARS-COV-2; Myocarditis; BNT162b2; Pfizer-BioNTech; Vaccine
Categories
Ask authors/readers for more resources
The widespread use of vaccines has been associated with rare but serious complications in adults, leading to global concern. This case study highlights a young male patient who developed acute myocarditis three days after receiving the second dose of the BNT162b2 vaccine.
The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine. (C) 2021 The Author(s). Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available